Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 1.00 |
| ▸ | TERT | O14746 | 3/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | APEX1 | P27695 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | MMP1 | P03956 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.60 |
| ▸ | XDH | P47989 | 1/20 | 0.60 |
| ▸ | PLG | P00747 | 1/20 | 0.59 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.59 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.57 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31682991 | 1.00 | APP (1.00) | APPTERTKDM4EMEN1MAPT | |
| SCHEMBL35304 | 0.91 | APP (0.84) | APPTERTKDM4EMEN1MAPT | |
| SCHEMBL28963475 | 0.91 | APP (0.83) | APPTERTKDM4EMEN1MAPT | |
| SCHEMBL8511950 | 0.85 | APP (0.74) | APPTERTKDM4EMEN1MAPT | |
| SCHEMBL30117602 | 0.84 | APP (0.73) | APPTERTKDM4EMEN1MAPT | |
| SCHEMBL31682973 | 0.83 | TERT (0.76) | APPTERTKDM4EMEN1MAPT | |
| SCHEMBL34972 | 0.83 | TERT (0.76) | APPTERTKDM4EMEN1MAPT | |
| SCHEMBL14259678 | 0.81 | TUBB4A (0.74) | APPKDM4EMEN1MAPTAPEX1 | |
| SCHEMBL7655891 | 0.81 | APP (0.67) | APPTERTKDM4EMEN1MAPT | |
| SCHEMBL34716 | 0.81 | KDM4E (0.73) | APPKDM4EMEN1MAPTAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130189383-A1 | USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | NATIONAL TAIWAN UNIVERSITY (TW) | 2013-07-25 | — | — | US | claimed |
| US-8414936-B2 | Use of Acacia extracts and their compounds on inhibition of xanthine oxidase | NATIONAL TAIWAN UNIVERSITY (TW) | 2013-04-09 | — | — | US | claimed |
| US-20120009288-A1 | USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-01-12 | — | — | US | claimed |
| US-20100310688-A1 | ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | NATIONAL TAIWAN UNIVERSITY (TW) | 2010-12-09 | — | — | US | claimed |
| US-20250281560-A1 | METHOD FOR PREVENTING AND/OR TREATING CANCER OR AUTOIMMUNE DISEASE WITH 3,4,2 Prime,3 Prime,4 Prime-PENTAHYDROXY-TRANS-CHALCONE | NATIONAL CHUNG HSING UNIVERSITY (TW) | 2025-09-11 | — | — | US | disclosed |
| US-9833490-B1 | Drug combination for the treatment of infertility and its preparation methods and applications | SICHUAN SHANZE BIOTECH., LTD. (CN) | 2017-12-05 | — | — | US | disclosed |
| US-8877260-B2 | Use of acacia extracts and their compounds on inhibition of xanthine oxidase | NATIONAL TAIWAN UNIVERSITY (TW) | 2014-11-04 | — | — | US | disclosed |
| US-8877260-B2 | Use of acacia extracts and their compounds on inhibition of xanthine oxidase | NATIONAL TAIWAN UNIVERSITY (TW) | 2014-11-04 | — | — | US | disclosed |
| US-20130189383-A1 | USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | NATIONAL TAIWAN UNIVERSITY (TW) | 2013-07-25 | — | — | US | disclosed |
| US-20130189383-A1 | USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | NATIONAL TAIWAN UNIVERSITY (TW) | 2013-07-25 | — | — | US | disclosed |
| US-8414936-B2 | Use of Acacia extracts and their compounds on inhibition of xanthine oxidase | NATIONAL TAIWAN UNIVERSITY (TW) | 2013-04-09 | — | — | US | disclosed |
| US-8414936-B2 | Use of Acacia extracts and their compounds on inhibition of xanthine oxidase | NATIONAL TAIWAN UNIVERSITY (TW) | 2013-04-09 | — | — | US | disclosed |
| US-20120009288-A1 | USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-01-12 | — | — | US | disclosed |
| US-20120009288-A1 | USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-01-12 | — | — | US | disclosed |
| US-20100310688-A1 | ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | NATIONAL TAIWAN UNIVERSITY (TW) | 2010-12-09 | — | — | US | disclosed |
| US-20100310688-A1 | ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | NATIONAL TAIWAN UNIVERSITY (TW) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120009288-A1 | USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | XDH, AOX1, ACACA | APP 2870/4885TERT 2205/4885KDM4E 1981/4885 |
| US-20100310688-A1 | ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | XDH, ACACA, ACAT1 | APP 2424/4885TERT 2114/4885KDM4E 1895/4885 |
| US-20130189383-A1 | USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | XDH, AOX1, ACACA | APP 2870/4885TERT 2205/4885KDM4E 1981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.